Liberia declares Ebola emergency

President announces quarantine for villages and counties

Hammond holds emergency meeting on Ebola

Government ‘absolutely focused’ on implications for Britain

AstraZeneca deal targets Almirall drugs

Spanish group’s respiratory portfolio rights worth up to $1.22bn

Review: Mental Illness at Work

A well-intentioned and practical guide to a stigmatised issue

Food industry boosts labelling lobbying

States roll out laws disclosing genetically modified ingredients

Pfizer refuses to rule out tax deals

US drugmaker calls for ‘fundamental reform’

£5.8bn of NHS work could go private

Slow rate of contract awards disappoints healthcare market

Ebola stirs noise – unlike other killers

Both the deadly virus and old scourges can be stopped by long-term strategies, says Peter Piot

Lloyds traders rip off an Old Lady

Scam is most dispiriting in scandal over benchmark manipulation

Drugmakers juggle non-core assets

Reckitt’s planned spin-off comes as groups focus on strengths

Borders closed to tackle Ebola outbreak

More than 700 dead in West Africa so far

Reckitt pushes ahead with pharma spin-off

UK group to divest heroin substitute business via London listing

GSK and Reckitt: pharming out

Moves to split businesses make sense where there is little operational crossover

Q&A: Why Ebola is causing such concern

Meditate to sharpen your assertive edge

Type-A personalities should not fear being tamed by the practice

Advances prompt calls for improved detection and prevention

The latest breakthrough has enhanced the status of experts in the disease and stirred up political controversy over pricing

Politics of prevention is part of the cure

Education and sterile syringes could limit disease’s spread

Global push can bring remedies within reach of all who need them

The World Health Organisation is committed to being part of the effort to reduce the price of hepatitis C medicines

Witty comes out fighting GSK’s corner

GSK chief floats break-up option

Witty signals willingness to shake up drug group


More FT Twitter accounts